Compare Agilent Technologies Inc (A) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Inovio Pharmaceuticals Inc — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.22B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: Agilent Technologies Inc is far larger — about 537.5× Inovio Pharmaceuticals Inc's market cap, and Agilent Technologies Inc pays a 0.68% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| A | INO | |
|---|---|---|
Market Cap | $42.22B | $78.55M |
Sector | Health | Health |
52-Week High | $157.20 | $2.87 |
52-Week Low | $110.24 | $0.66 |
Enterprise Value | $43.77B | $49.56M |
Dividend Yield | 0.68% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
